Want to join the conversation?
$GILD, which owns products like Stribild, Atripla and Truvad, said that total 2Q16 revenues were $7.8Bil vs. $8.2Bil in 2Q15. Product sales were $7.7Bil, down 6% vs. 2Q15. The YoverY decline was driven by lower HCV sales, partially offset by increased sales in HIV and other therapeutic areas. US product sales were $4.9Bil, down 12% YoverY.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.